-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Desidustat in Chemotherapy Induced Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Desidustat in Chemotherapy Induced Anemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Desidustat in Chemotherapy Induced Anemia Drug Details: Desidustat (Oxemia) is an erythropoietin-stimulating...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mesdopetam in Drug-Induced Dyskinesia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mesdopetam in Drug-Induced Dyskinesia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mesdopetam in Drug-Induced Dyskinesia Drug Details: Mesdopetam (IRL-790) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VLX-1005 in Heparin-Induced Thrombocytopenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VLX-1005 in Heparin-Induced Thrombocytopenia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VLX-1005 in Heparin-Induced Thrombocytopenia Drug Details: VLX-1005 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ibudilast in Chemotherapy Induced Peripheral Neuropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ibudilast in Chemotherapy Induced Peripheral Neuropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ibudilast in Chemotherapy Induced Peripheral Neuropathy Drug Details: Ibudilast (Ketas)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Melatonin in Chemotherapy Induced Oral Mucositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Melatonin in Chemotherapy Induced Oral Mucositis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Melatonin in Chemotherapy Induced Oral Mucositis Drug Details: Melatonin (SP-13004)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Olanzapine in Chemotherapy Induced Nausea and Vomiting
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Olanzapine in Chemotherapy Induced Nausea and Vomiting report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Olanzapine in Chemotherapy Induced Nausea and Vomiting Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ferric Carboxymaltose in Chemotherapy Induced Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ferric Carboxymaltose in Chemotherapy Induced Anemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ferric Carboxymaltose in Chemotherapy Induced Anemia Drug Details: Ferric carboxymaltose...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy Drug Details: Tetrodotoxin (TTX,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TBI-304H in Chemotherapy Induced Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TBI-304H in Chemotherapy Induced Anemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TBI-304H in Chemotherapy Induced Anemia Drug Details: TBI-304H is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Romyelocel-L in Chemotherapy Induced Neutropenia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Romyelocel-L in Chemotherapy Induced Neutropenia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Romyelocel-L in Chemotherapy Induced Neutropenia Drug Details: Romyelocel L (CLT-008) is...